It binds to the growth hormone secretagogue receptor (GHS-R1a), stimulating pulsatile release of growth hormone from the anterior pituitary
The result is your concentration in mcg/mL
Review the sources used below for this article: This article references information from a study published in the American Journal of Physiology: Actions of Gila monster venom on dispersed acini from guinea pig pancreas This article references information from the NIH: Exendin-4: From lizard to laboratory...and beyond This article references information from a study published in The Journal Of Biological Chemistry: Isolation and Characterization of Exendin-4, an Exendin-3 Analogue, from Heloderma suspecturn Venom This article references information from the University of Queensland: The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs
Individuals who undergo frequent aesthetic treatments such as microneedling, laser, peels, or dermaplaning often find that GHK-Cu peptides significantly reduce downtime, redness, and inflammation while accelerating recovery
Clinical trials show average losses of around 15% of body weight for semaglutide and 2022% for tirzepatide, but those are averages over 68+ weeks, not a 30-day result
Quite remarkably, in those with low POP levels, the typically robust association between diabetes and obesity was not observed in a nested case-controlled study, suggesting that obesity may exaggerate the metabolic disturbances caused by POPs (perhaps because adipose tissue provides a reservoir for fat-soluble toxins), rather than being directly responsible for the altered metabolism
